Table 4 Proportions of TERC/C-MYC amplification types in cervical disorders
| Â | TERC positive | C-MYC positive | ||
|---|---|---|---|---|
Histological diagnosis | CIN2+ | Normal/CIN1 | CIN2+ | Normal/CIN1 |
Case no. | 45 | 20 | 40 | 43 |
Abnormal nuclei (no.) | 963 | 213 | 854 | 293 |
Abnormal nuclei (%) | 21.1 | 10.2 | 20.9 | 6.2 |
Distribution of GCN (%) | ||||
3 copies | 27.7 | 55.9 | 48.0 | 49.5 |
4 copies | 31.9 | 25.4 | 35.5 | 39.9 |
5 copies | 16.5 | 10.8 | 9.6 | 7.2 |
6 copies | 7.1 | 5.6 | 3.9 | 1.7 |
≥ 7 copies | 16.8 | 2.3 | 3.0 | 1.7 |
Distribution of TERC: CEP3 ratios (%) | ||||
< 1 | 4.0 | 5.2 | Â | Â |
= 1 | 26.9 | 33.8 | Â | Â |
> 1 | 69.1 | 61.0 | Â | Â |